As of June 30, 2023, cash, cash equivalents and marketable securities were $29.6 million, compared to $33.6 million on March 31, 2023.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See today’s best-performing stocks on TipRanks >>
Read More on MDNA:
- Medicenna Reports First Quarter Fiscal 2024 Financial Results and Operational Highlights
- Medicenna Therapeutics to present as NBTS Research Roundtable
- Medicenna Presents at National Brain Tumor Society’s Research Round Table
- Medicenna Therapeutics extends period to exercise certain warrants
- Oppenheimer waiting for further clinical updates on Medicenna Therapeutics